BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 7, 2011
View Archived Issues
Theophylline improves motor function after stroke
Read More
Vitae and Boehringer Ingelheim claim new 11-beta-HSD1 inhibitors
Read More
New protein glutamine gamma-glutaminyltransferase 2 inhibitors presented
Read More
Verona Pharma provides update on clinical development programs
Read More
Sylentis gains approval in Spain to conduct trials of RNAi therapy SYL-1001
Read More
Mologen to investigate DNA immunomodulator MGN-1703 in lung cancer
Read More
Interim first-in-human data suggest MK-1496 is active against solid tumors
Read More
First-in-human phase 0/Ia SM-101 study in healthy volunteers completed
Read More
Abagovomab does not prolong survival of patients with ovarian cancer in MIMOSA trial
Read More
Liraglutide added to insulin shows promise in treating type 1 diabetes
Read More
Merck KGaA prepares novel PI3K inhibitors
Read More
Mellitech researchers disclose new insulin secretagogues
Read More
GSK presents new serine/threonine-protein kinase B-raf inhibitors
Read More
SPX-106 with D-tagatose significantly reduces cholesterol and triglycerides in mice
Read More
Grifols completes acquisition of Talecris Biotherapeutics
Read More
Evotec and Active Biotech form medicinal chemistry collaboration
Read More
GE Healthcare and ImaginAb to develop PET imaging agents based on antibody fragments
Read More
NovaDel Pharma files IND with FDA for sildenafil oral spray
Read More
AIM Therapeutics begins first-in-human phase I trial of AIM-102
Read More
Ferrer files MAA with EMA for tesamorelin
Read More
Plexxikon provides update on vemurafenib development program
Read More
Adolor completes enrollment in phase II ADL-5945 program
Read More
Seaside Therapeutics begins pivotal phase III STX-209 trial in fragile X syndrome
Read More
NICE recommends Ozurdex to treat for macular edema due to retinal vein occlusion
Read More
Laureate Biopharmaceutical to manufacture Patrys' lead anticancer product, PAT-LM1
Read More